Regu 33 of LODR Regulation 2015

Revenue declinedProfit growth above 25%Negative operating cash flowResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.0%Reaction day

₹23.24

prior close

₹24.24

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.8%-1.8% vs market

Pharmaceuticals peers, median of 150sector+0.2%-1.1% vs sector

On the reaction day the stock moved 1.8 pts less than Nifty Microcap 250 and 1.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.0+0.8-1.8+0.2-1.1

Next day

-3.9+2.0-5.9+1.1-5.1

+2.8+0.9+1.9+0.1+2.7

-1.2+1.7-2.8+1.0-2.2

-3.1+1.6-4.7+1.2-4.3

+1.1+2.2-1.1+0.7+0.4

+1.1+2.7-1.6+1.4-0.3

15d

+4.3+4.5-0.2+0.6+3.7

+3.3+5.6-2.3+2.1+1.2

+21.3+9.0+12.4+3.8+17.5

+6.2+3.5+2.6-1.0+7.1

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 150Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board of Directors of Unjha Formulations Ltd approved the audited financial results for Q4 and FY ended 31 March 2025 at a meeting held on 16 May 2025. Full-year FY25 revenue from operations declined about 24.5% to Rs. 1,397.68 lacs from Rs. 1,850.75 lacs in FY24. Despite the revenue fall, full-year profit after tax rose roughly 47% to Rs. 40.76 lacs from Rs. 27.79 lacs, helped by lower material and finance costs. Q4 FY25 however swung to a loss of Rs. 40.64 lacs versus a profit of Rs. 22.40 lacs in the preceding quarter. Net cash from operating activities turned negative at Rs. -4.49 lacs compared with a positive Rs. 102.61 lacs a year ago. The statutory auditor Jain & Golechha issued an unmodified (clean) opinion. The Board also appointed M/s Ajay Parikh & Associates as Secretarial Auditor for five years from FY26 to FY30, subject to shareholder approval.

Likely market impact

Sharp revenue decline, negative operating cash flow, and continued negative other equity (Rs. -134.17 lacs) are red flags for shareholders, even though bottom-line improved on cost cuts. Q4 loss reversal and weak cash generation may pressure the stock in the near term.